Financial Analysis: Ambu A/S (AMBBY) & Its Peers

Ambu A/S (OTCMKTS:AMBBY) is one of 664 publicly-traded companies in the “Holding & other investment offices” industry, but how does it compare to its competitors? We will compare Ambu A/S to related companies based on the strength of its risk, earnings, valuation, profitability, dividends, analyst recommendations and institutional ownership.

Valuation and Earnings

This table compares Ambu A/S and its competitors top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Ambu A/S	$684.73 million	$24.09 million	100.66
Ambu A/S Competitors	$1.17 billion	$87.81 million	47.44

Ambu A/S’s competitors have higher revenue and earnings than Ambu A/S. Ambu A/S is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Profitability

This table compares Ambu A/S and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Ambu A/S	7.23%	6.80%	5.32%
Ambu A/S Competitors	-24.81%	-46.30%	-1.24%

Insider and Institutional Ownership

54.2% of shares of all “Holding & other investment offices” companies are owned by institutional investors. 25.4% of shares of all “Holding & other investment offices” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Ambu A/S and its competitors, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ambu A/S	0	0	1	0	3.00
Ambu A/S Competitors	126	559	858	14	2.49

As a group, “Holding & other investment offices” companies have a potential upside of 75.27%. Given Ambu A/S’s competitors higher possible upside, analysts plainly believe Ambu A/S has less favorable growth aspects than its competitors.

Ambu A/S Company Profile

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. The company was founded in 1937 and is headquartered in Ballerup, Denmark.